Source: Annual Congress 2006 - Pneumonia and other invasive pulmonary infections in children
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. F. Patria, N. Liotto, R. M. Dellepiane, A. Lopopolo, M. C. Pietrogrande (Milan, Italy). Outcome of pulmonary disease in patients with primary humoral immunodeficiencies. Eur Respir J 2006; 28: Suppl. 50, 1792

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary and sinus diseases in primary humoral immunodeficiencies Source: Eur Respir J 2004; 24: Suppl. 48, 640s Year: 2004 Assessment of innate immunity mediators in the lung of COPD patients: relation with disease manifestations Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity Year: 2020 Pulmonary disease in primary immunodeficiencies in children: a report of 61 cases Source: Annual Congress 2008 - Pulmonary infections in children - rare but important aspects Year: 2008 Pulmonary complications in patients with hematologic diseases Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach Year: 2012 Association between congenital pulmonary disease and primary immunodeficiency in the bronchiectasis patients Source: Eur Respir J 2005; 26: Suppl. 49, 376s Year: 2005 Pulmonary and systemic cellular immune response network in patients with mild-moderate COPD Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 Respiratory system disturbances in the course of immunodeficiencies in patients after thymectomy Source: Eur Respir J 2003; 22: Suppl. 45, 228s Year: 2003 Evaluation of tuberculosis risk in patients submitted to chronic immunosuppressive therapy for osteoarticular immune disease Source: Eur Respir J 2006; 28: Suppl. 50, 131s Year: 2006 Primary immunodeficiencies: not just paediatric diseases Source: Eur Respir J 2015; 45: 1521-1523 Year: 2015 Lung manifestations of chronic granulomatous disease; a clinical survey of patients from the Iranian primary immunodeficiency registry Source: Eur Respir J 2001; 18: Suppl. 33, 510s Year: 2001 Non-infectious pulmonary complications in immunocompromised (IC) patients. Associated pulmonary and systemic inflammatory response Source: Eur Respir J 2004; 24: Suppl. 48, 241s Year: 2004 Outcome of pulmonary hypertension associated with respiratory disease Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019 Impact of underlying respiratory diseases on clinical features and prognosis of chronic pulmonary aspergillosis Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Evaluation of specific immune complexes in patients with pulmonary sarcoidosis. Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management Year: 2018 Respiratory disease in a cohort of patients with primary antibody deficiency Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Prognosis in patients with primary pulmonary hypertension awaiting lung transplantion Source: Eur Respir J 2001; 18: Suppl. 33, 297s Year: 2001 Clinical features and outcomes of patients with myositis associated-interstitial lung disease Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Clinical characteristics of immunocompetent patients with pulmonary cryptococcosis Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012 Risk factors for pulmonary Mycobacterium avium-intracellulare complex disease deterioration in immunocompetent patients Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry Source: ERJ Open Res, 5 (3) 00170-2018; 10.1183/23120541.00170-2018 Year: 2019